This page shows the latest formoterol news and features for those working in and with pharma, biotech and healthcare.
Sales in AZ’s respiratory franchise were also better-than-expected, with sales of asthma treatment Symbicort (budesonide and formoterol fumarate dihydrate) increasing by 12% to bring in $653m – around $90m
its chronic obstructive pulmonary disease (COPD) therapy PT010 (budesonide/glycopyrronium/formoterol fumarate).
In KRONOS, there was a 52% reduction in the rate of moderate or severe COPD exacerbations with Breztri compared with AZ’s two-drug Bevespi glycopyrronium/formoterol fumarate, and a 17% ... Breztri – which combines long-acting beta agonist (LABA)
Duaklir (aclidinium/formoterol) which is under regulatory review in the US with a verdict due by the end of March.
The KRONOS trial of PT010 – which combines long-acting beta agonist (LABA) formoterol fumarate, long-acting muscarinic antagonist (LAMA) glycopyrronium and inhaled corticosteroid (ICS) budesonide – was presented at a medical congress ... It was
The results of the AERISTO trial are a blow to AZ’s ambitions for Bevespi (glycopyrronium/formoterol fumarate) – a long-acting muscarinic agonist (LAMA)/long-acting beta agonist (LABA) combination that ... while AZ’s PT010
More from news
Approximately 0 fully matching, plus 76 partially matching documents found.
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...